Related Experiment Videos

[Juvenile rheumatoid arthritis]

Shumpei Yokota¹

¹Department of Pediatrics, Yokohama City University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine

|June 16, 2005

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Long-term efficacy and safety of canakinumab in the treatment of systemic juvenile idiopathic arthritis in Japanese patients: Results from an open-label Phase III study.

Modern rheumatology·2022

Novel Coronavirus Disease 2019 (COVID-19) and Cytokine Storms for More Effective Treatments from an Inflammatory Pathophysiology.

Journal of clinical medicine·2021

Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients.

Modern rheumatology·2020

Safety and effectiveness of adalimumab in Japanese patients with juvenile idiopathic arthritis: Results from a real-world postmarketing study.

Modern rheumatology·2020

Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study.

Rheumatology (Oxford, England)·2020

Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.

Pediatric rheumatology online journal·2019

See all related articles